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Despite the ban of nitrofurans (NFs) for use in food production in many countries in the 20 
1990s, NF metabolites in food are still regularly detected during import control testing. We 21 
have developed a confirmatory routine method for the detection and quantification of NF 22 
metabolites in seafood using LC-MS/MS and validated the method according to the strict 23 
criteria in European legislation and Codex Alimentarius. Method characteristics were found to 24 
fulfill the criteria. We report for the first time a new false positive for 1-amino-2,4-25 
imidazolidinedione (AHD), the metabolite of Nitrofurantoin (NFT). By using optimized 26 
washing procedures, the non tissue bound false positives can be minimized. The results from 27 
the validation on both lean and fatty fish and crustaceans, results from proficiency tests and 28 
routine use over many years, demonstrates that the method is fit for purpose to determine NF 29 
metabolites in the seafood category. 30 
 31 
Keywords: nitrofurans; LC-MS/MS; seafood; false positive 32 
  33 
3 
 
1. Introduction 34 
During World War II it was discovered that Schiff base derivatives of nitrofuraldehyde 35 
were effective against pathogenic bacteria, leading to extensive research and synthesis of such 36 
compounds (McCalla, 1983). Nitrofurans (NFs) are comprised of a Sciff base of a 37 
nitrofuraldehyde and are part of the large family of hydrazide compounds characterized by the 38 
RC(=O)NRNR2 functional group (Moss, Smith, & Tavernier, 1995). NFs are broad-spectrum 39 
synthetic antibiotics, effective against both Gram-negative and Gram-positive bacteria. Under 40 
the World Health Organisation (WHO) Anatomical Therapeutic Chemical (ATC) 41 
classification system they are categorization both as antiinfectives for systemic use (J01XE), 42 
dermatologicals - antiseptics and disinfectants (D08AF) and antiparasitic products, 43 
insecticides and repellents - antiprotozoals - agents against leishmaniasis and trypanosomiasis 44 
(P01CC) (WHO). One of the advantages of using NFs is that resistance appears to develop 45 
slowly towards this class of antibiotics. NFs have been used as feed additives for growth 46 
promotion in domesticated animals and have been used both prophylactically and 47 
therapeutically to treat gastrointestinal infections, such as bacterial enteritis caused by 48 
Escherichia coli and Salmonella. 49 
The main NFs used in animal production are furazolidone (FZD, 3-{(E)-[(5-nitro-2-50 
furyl)methylene]amino}-1,3-oxazolidin-2-one), furaltadone (FTD, 5-(4-morpholinylmethyl)-51 
3-{(E)-[(E)-(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one), nitrofurazone (NFZ, 52 
(2E)-2-[(5-nitro-2-furyl)methylene]hydrazinecarboxamide) and nitrofurantoin (NFT, 1-{(E)-53 
[(5-nitro-2-furyl)methylene]amino}-2,4-imidazolidinedione). Upon ingestion, these NFs are 54 
metabolized within minutes to their respective NF metabolites; 3-amino-1,3-oxazolidin-2-one 55 
(AOZ), 3-amino-5-(4-morpholinylmethyl)-1,3-oxazolidin-2-one (AMOZ), 56 
hydrazinecarboxamide (usually referred to as semicarbazide (SEM)) and 1-amino-2,4-57 
imidazolidinedione (usually referred to as 1-aminohydantoin (AHD)). These NF metabolites 58 
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are more persistent than the parent NFs and can prevail for weeks after treatment, covalently 59 
bound to muscle protein in treated animals. 60 
In 1991 the U.S. Food and Drug Administration (FDA) withdrew the approvals for 61 
FZD and NFZ, and in 1995 the use of NFs in livestock production was banned in the EU due 62 
to concerns regarding the carcinogenic and mutagenic properties of NFs and potential harmful 63 
effects on human health (EC, 1993, 1995). Following their ban, a minimum required 64 
performance level (MRPL) was established for methods to be used in official control of NF 65 
metabolites at 1 µg/kg in the EU. The MRPL is implemented in the analytical method as the 66 
decision limit (CCα) which is the limit at and above it can be concluded with an error 67 
probability of α that a sample is non-compliant. The implications of this is that any detections 68 
of NF metabolites, above the CCα of the confirmatory method used for the determination, is 69 
evidence of illegal use of NFs. Codex Alimentarius Commission (CAC) has developed risk 70 
management recommendations for FZD and nitrofural (another name for NFZ) to prevent 71 
residues of these NFs in food (CAC, 2018). 72 
The number of detections of NF metabolites has decreased since the peak years at the 73 
beginning of the millennium, possibly due to a combination of increased food import control 74 
and decreased use. Residues of NFs are still regularly detected during EU import control of 75 
aquaculture products such as e.g. fish and crustaceans as reported in the Rapid Alert System 76 
for Food and Feed (RASFF) (RASFF). The main NF metabolites detected are SEM and AOZ, 77 
whereas AMOZ was more prominent in the early 2000s compared to present days. For SEM 78 
there is a known problem of false positives in foods due to the use of additives in both food 79 
packaging and food, which will result in identical analytical response (de la Calle & Anklam, 80 
2005). 81 
While early methods focused on the determination of the parent NFs, the lack of 82 
stability of the parent NFs has forced a change of analytical methodology focus towards 83 
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methods which determine NF metabolites. Because NF metabolites have high polarity and 84 
low molecular mass the detection and quantification is usually carried out after derivatization 85 
with 2-nitrobenzaldehyde (2-NBA). Following derivatization of the metabolites, 3-[(E)-(2-86 
Nitrobenzylidene)amino]-1,3-oxazolidin-2-one (NP-AOZ), 5-(4-Morpholinylmethyl)-3-[(E)-87 
(2-nitrobenzylidene)amino]-1,3-oxazolidin-2-one (NP-AMOZ), (2E)-2-(2-88 
Nitrobenzylidene)hydrazinecarboxamide (NP-SEM) and 3-[(E)-(2-Nitrobenzylidene)amino]-89 
2,4-imidazolidinedione (NP-AHD) are obtained. Sample workup and derivatization of NF 90 
metabolites are usually carried out based on the published methods from Hoogenboom et. al. 91 
and Leitner et. al. (Hoogenboom, Vankammen, Berghmans, Koeman, & Kuiper, 1991; 92 
Leitner, Zollner, & Lindner, 2001). 93 
Different instrument setups for the detection and quantification of NF metabolites 94 
have been published using LC with either ultraviolet (UV) or mass spectrometry (MS) as 95 
detectors (Conneely, Nugent, O'Keeffe, Mulder, van Rhijn, Kovacsics, et al., 2003; Hu, Xu, & 96 
Yediler, 2007). Whereas UV is more cost beneficial, the use of MS is more selective and may 97 
fulfill requirements for unequivocal identification of the metabolites. Both MS, MS/MS and 98 
ion-trap MS have been used for the determination of NF metabolites. The use of MS/MS is 99 
often preferred due to higher selectivity compared to single quadrupole MS and better 100 
reproducibility compared to ion-trap-MS (Saari & Peltonen, 2004). Using two transitions for 101 
the identification and quantification of NF metabolites in MS/MS, fulfills the point system for 102 
unequivocal detection of an illegal substance (CAC, 2014; EC, 2002). 103 
Several methods for the determination of various NF metabolites in foods such as egg, 104 
chicken, pork, poultry, dairy products, feed, bakery products and baby food have been 105 
developed (Vass, Hruska, & Franek, 2008). No method for the determination of all NF 106 
metabolites demonstrated to be applicable to seafood as a food category has previously been 107 
published, but methods for the LC-MS/MS determination of AOZ in prawns, SEM in 108 
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crayfish, prawns, shrimp and fish, FZD and AOZ in fish and AOZ, AMOZ, AHD and SEM in 109 
shrimp has been published (Chu & Lopez, 2005; Conneely, et al., 2003; Hoenicke, 110 
Gatermann, Hartig, Mandix, & Otte, 2004; Hu, Xu, & Yediler, 2007; Saari & Peltonen, 2004; 111 
Valera-Tarifa, Plaza-Bolanos, Romero-Gonzalez, Martinez-Vidal, & Garrido-Frenich, 2013). 112 
Important validation parameters such as e.g. recovery and/or CCα/CCβ are also missing in 113 
several of the methods published earlier. We hypothesized that it would be possible to 114 
develop a horizontal method applicable to seafood as a food category and report here our 115 
findings after comprehensive validation of a method for the determination of NF metabolites 116 
in seafood, carried out according to the current EU decision 657/2002/EC and Codex 117 
Guideline 71-2009 (CAC, 2014; EC, 2002). 118 
 119 
2. Material and methods 120 
2.1 Samples 121 
Samples of seafood were selected to represent both variety in matrix composition and seafood 122 
where NF metabolites are often detected, such as crustaceans. Atlantic salmon (Salmo salar) 123 
was used as a matrix representing fish with high fat content and atlantic cod (Gadus morhua) 124 
represented fish with low fat content. Shrimp (Pandalus borealis) was used as a proxy for 125 
crustaceans. Validation samples were obtained from regular monitoring samples collected 126 
routinely by our institute and the Norwegian Food Safety Autority. Samples did not contain 127 
NF metabolites. The wild cod and shrimp were collected by fishermen authorized for 128 
commercial fishing by the Norwegian Directorate of Fisheries. Both wild cod, shrimp and 129 
farmed salmon were treated according to Norwegian laws regulating handling and euthanasia 130 




2.2 Standards 133 
Unlabeled NF metabolites AOZ, AMOZ, AHD and SEM (VETRANAL, ≥ 98% purity) were 134 




13C were purchased from Witega (Berlin, DE). Stock solutions 136 
used for establishing calibration curves and for spiking of control samples were prepared 137 
independently. Stock solutions of unlabeled analytes used in calibration curves and control 138 
samples, and labeled analytes used as internal standards, were prepared by weighing 15-25 139 
mg of the compounds. The weighed amount of unlabeled AMOZ and AOZ was transferred 140 
into a 20 ml volumetric flask followed by diluting to the mark with methanol (Chromasolv, 141 
Sigma Aldrich). Stock solution of unlabeled AHD was prepared by transfering the weighed 142 
amount into a 100 ml volumetric flask, followed by diluting to the mark with methanol. For 143 
unlabeled SEM the weighed amount was transferred into a 250 ml volumetric flask, followed 144 
by diluting to the mark with Milli Q water. The weighed amount of the labeled internal 145 
standards were all transferred into 100 ml volumetric flasks and diluted to the mark with 146 
methanol, except for SEM which was diluted with Milli Q water. All stock solutions were 147 
diluted to intermediate mixture solutions by adding an appropriate amount of each stock 148 
solution to a 10 ml volumetric flask and diluting to the mark with methanol. Nominal 149 
concentrations (in parenthesis) for intermediate mixture solution were; calibration curves (10 150 
µg/ml), internal standards (2-10 µg/ml) and control solutions (4-6 µg/ml). Working standard 151 
solutions in the ng/ml range were prepared by adding an appropriate amount of the 152 
intermediate solutions to 100 ml volumetric flasks and diluting to the mark with methanol. 153 
 154 
2.3 Reagents 155 
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The extraction solution, 0.2 M hydrochloric acid (HCl), was prepared by adding 16.7 ml of 156 
concentrated HCl (12 M, 37%, Merck, Darmstadt, DE) to 300 ml Milli Q water in a 1 L 157 
volumetric flask followed by diluting to the mark with Milli Q water. Derivatization reagent 158 
(100 mM) was prepared by weighing 76 mg 2-NBA (p.a., Sigma Aldrich) into a 5 ml 159 
volumetric flask and diluting to the mark with methanol (Chromasolv, Sigma-Aldrich). The 2 160 
M sodium hydroxide  solution was prepared by weighing 20 g NaOH (Merck) in a 250 ml 161 
volumetric flask, followed by dissolving the NaOH in Milli Q water and finally diluting to the 162 
mark. The 0.3 M trisodiumfosfate buffer solution was prepared by weighing 11.4 g 163 
Na3PO4·12H2O (Merck) into a 100 ml volumetric flask followed by diluting to the mark with 164 
milli Q water. Mobile phase A for the LC was prepared by adding 1 ml concentrated acetic 165 
acid (100%, glacial, anhydrous for analysis EMSURE®, Merck) to a 1 L mixture of 900 ml 166 
acetonitrile and 100 ml Milli Q water. Mobile phase B was prepared by adding 1 ml 167 
concentrated acetic acid to 1 L of Milli Q water. In addition to the aforementioned Milli Q 168 
water and methanol, hexane (Merck) was used for sample cleanup and ethanol (Kemetyl, 169 
Kolbotn, NO) and diethyl ether (Merck) was used for the washing procedures (2.4). End 170 
solution was prepared by mixing 25 ml acetonitrile with 225 ml Milli Q water and adding 250 171 
µl concentrated acetic acid. 172 
 173 
2.4 Washing procedure for tissue bound NF metabolites 174 
Two different procedures were used for determination of tissue bound residues of NF 175 
metabolites. Both washing procedures were performed after weighing of the sample, but prior 176 
to the sample preparation (supplementary Figure 1) described in section 2.5. 177 
Washing procedure 1 was based on the report from the 2004 Joint FAO/WHO 178 
Technical Workshop on Residues of Veterinary Drugs without ADI/MRL (FAO/WHO, 179 
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2004). The sample was first homogenised with 5 ml ethanol/water (1/1; v/v), followed by 5 180 
min 4000 rpm centrifugation. The supernatant was then discarded. The sample was further 181 
washed three times with 5 ml of methanol, two times with 5 ml of ethanol and two times with 182 
5 ml of diethyl ether. Each time the sample was washed by addition of the solvent, turning the 183 
sample tube three times, and decanting off the solvent before the next washing step. 184 
Following washing and decanting of the last washing solvent, the procedure described under 185 
sample preparation (2.5) was carried out. 186 
Washing procedure 2 was based on the method used by the European Reference 187 
Laboratory (EURL) for residues of veterinary medicines and contaminants in food of animal 188 
origin (Eric Verdon, Couedor, & Sanders, 2007). In this procedure the sample was washed 189 
four times, first with 6 ml of methanol/water solution (1/1; v/v), then with 6 ml of 190 
methanol/water solution (3/1; v/v), followed by 6 ml of methanol and finally 2 ml of Milli Q 191 
water. Each time the addition of washing solvent was followed by a 15 min rotary 192 
homogenization at 100 rpm, before centrifugation for 10 min at 4000 rpm and disposal of the 193 
supernatant by decantation. Following the washing and decanting of the milli Q water, the 194 
procedure described in sample preparation (2.5) was carried out. 195 
 196 
2.5 Sample preparation 197 
Sample weighing for validation and later routine use was identical. Homogenized samples 198 
were weighed (1.00±0.02 g) into polypropylene (PP)-tubes. It is important to make sure that 199 
the analytical test portion is sufficiently large and homogeneous to produce representative 200 
results of the sample. During validation matrix blank for positive controls were spiked with 201 
appropriate volumes of a 10 ng/ml working standard mixture of NF metabolites. During later 202 
routine use, when the CCα of the method had been established, the matrix blank for positive 203 
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control was spiked with 100 µl of a 4-6 ng/ml working standard mixture of NF metabolites. 204 
Calibration curve solutions were prepared by adding 10-1000 µl of a 10 ng/ml working 205 
standard mixture to PP-tubes. Calibration curves with 5-6 concentrations in the range 0.1-10 206 
ng of each NF metabolite were prepared fresh from the stock solutions every day. All samples 207 
and calibration curve solutions were then spiked with 100 µl of a 20-100 ng/ml internal 208 
standard mixture solution. The derivatization agent, 2-NBA, (50 µl of the 100 mM solution) 209 
was added to all samples, matrix blanks and calibration curve solutions . Then 5 ml of 0.2 M 210 
HCl were added to samples and matrix blanks and 1 ml 0.2 M HCl was added to calibration 211 
curve solutions. A procedural blank was prepared by adding 50 µl of 2-NBA and 1 ml of 0.2 212 
M HCl to an empty tube. All tubes were vortex mixed for 1 minute and placed in a heating 213 
cabinet at 37±3 ºC overnight. The next morning samples were removed from the heating 214 
cabinet and allowed to cool down to room temperature. Then 0.3 M Na3PO4 solution was 215 
added to each sample and matrix blank (500 µl) and calibration curve solution (100 µl) 216 
followed by swirl mixing. The pH was adjusted to 7 ± 0.5 by adding 2 M NaOH to the 217 
samples and matrix blanks (340-370 µl), the procedural blank (340-370 µl) and calibration 218 
curve solutions (80 µl), followed by swirl mixing and waiting 5 minutes before the pH was 219 
checked using pH-paper. The amount of 2 M NaOH required to adjust the pH to 7 was found 220 
to be matrix dependent. Typical volumes of 2 M NaOH required to reach pH 7 was 340-360 221 
µl for salmon, 350 µl for shrimp, 350-360 µl for cod and 370 µl for the procedural blank. 222 
After the pH adjustment, 4 ml ethyl acetate was added to the samples and matrix blanks and 223 
the content of the tubes were mixed for 20 minutes using a rotator. Samples and matrix blanks 224 
were then centrifuged at 4000 rpm for 5 minutes, and the ethyl acetate was transferred to a 225 
new PP-tube. The extraction was repeated with 4 ml ethyl acetate and the combined extracts 226 
were filtered through a 0.2 µm nylon filter. The solvent was removed by evaporation at 30 ºC 227 
using a flow of nitrogen. The samples and matrix blanks were reconstituted in 250 µl of end 228 
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solution. Further clean up of the samples was done by adding 2 ml of hexane to the 229 
reconstituted sample, vortex mixing and centrifugation at 4000 rpm for 5 minutes. The bottom 230 
layer was transferred to vials for instrument determination. 231 
 232 
2.6 Instrument determination 233 
Samples were analysed using an Agilent 1200 LC, fitted with the large volume injecton kit 234 
allowing for volumes up to 100 µl to be injected. The LC was connected to an Agilent 6410B 235 
MS/MS fitted with a Zorbax Eclipse Plus C18 column (600 Bar), with particle size of 1.8 µm, 236 
internal diameter 2.1 mm and length 150 mm. The instrument sequence was set up according 237 
to Commission decision 2002/657/EC with minor adjustments. The validation sequence 238 
started with calibration curve solutions followed by procedural blanks, negative matrix 239 
blanks, (spiked) samples and calibration curve solutions. The sequence used for later routine 240 
followed the same setup except that the negative matrix blank and spiked sample at CCα were 241 
also analysed after the samples in the sequence. Injection volumes were 50 µl for all solutions 242 
expect calibration curve solutions at or above 1 ng, where 20-5 µl injection volumes were 243 
used. Flow rate was set at 0.25 ml/min and the column temperature was held at 45 ºC. The 244 
gradient started at 17 % A, which was held for 0.1 minutes before changing rapidly to 40% A 245 
in 0.01 min. This composition was held until 3.5 minutes. Then the composition was rapidly 246 
returned to initial conditions during 0.01 min, which was held until 10 minutes. The MS was 247 
operated in positive ESI MRM mode. Gas temperature was held at 350 ºC, gas flow was held 248 
at 6 L/min, nebulizer pressure was held at 15 psi and capillary was held at 3500 (V). Detailed 249 
MS-parameters are given in Table 1. 250 
 251 
2.7 Validation setup and calculation of validation results 252 
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Validation was carried out according to Codex guideline 71-2009 and EU Commission 253 
decision 2002/657/EC which lays down the parameters to be checked in the validation and the 254 
criteria for the evaluation of results and fitness for purpose of the method. The outline of the 255 
validation is shown in Table 2. 256 
Selectivity/specificity was evaluated by investigating chromatographic separation of 257 
the analytes, comparing peak shape in standards and samples. Matrix effects which could give 258 
interferences were evaluated by analyzing >20 blank samples of each matrix. 259 
Linear range of the method was evaluated by analysis of calibration curves and by 260 
determining the decision limit (CCα). The upper limit of quantification (ULOQ) was set equal 261 
to the concentration of the highest calibration curve standard.  262 
CCα was determined using the three methods described in Commission decision 263 
2002/657/EC. When using the first method CCα was determined by analyzing > 20 blank 264 
samples of each matrix (sample blank method) and using three times signal to noise (S/N) 265 
given by the formula 266 
 267 
𝐶𝐶𝛼 = 3 ∗ 𝑆/𝑁 268 
 269 
CCα was also determined using linear regression of the matrix blanks spiked at 1.0 x MRPL, 270 
1.5 x MRPL and 2.0 x MRPL as stated in Commission decision 2002/657/EC (calibration 271 
curve method). The CCα was determined by calculating > 20 calibration curves and 272 
determining the actual mean zero value of analyte and adding 2.33 standard deviations (SD) 273 
of the intercept as given in the formula 274 
 275 




The CCα was also determined using the ISO 11843 procedure referred to in Commission 278 
decision 2002/657/EC (ISO 11843 method) using the formula from Verdon et. al (E. Verdon, 279 

















where tα is the Student’s t-value at risk α and IJ-2 degrees of freedom, ?̂? is the estimated 284 
residual standard deviation of the regression function, ?̂? is the estimated slope of the 285 
calibration curve, ?̅? is the mean of the xij values, K is the number of replicates of the real 286 
state, I is the number of calibration levels and J is the number of replicates per level.  287 
Detection capability (CCβ) was determined by analyzing > 20 matrix blanks spiked at 288 
CCα and adding 1.64 SDs as specified in the formula 289 
 290 
𝐶𝐶𝛽 = 𝐶𝐶𝛼 + 1.64 𝑆𝐷[𝐶𝐶𝛼] 291 
 292 
Ion ratios of quantifier and qualifier in standards and samples were determined every day. 293 
Recovery was evaluated by spiking matrix blanks at 1.0 x MRPL, 1.5 x MRPL and 2.0 294 









Since there were no certified reference materials available at the time of validation, the 299 
trueness was evaluated by determining a proficiency test of shrimp containing SEM. 300 
Following validation, the method has participated regularly in proficiency tests. 301 
Precision, as repeatability, was determined by analyzing six replicates of salmon 302 
muscle spiked at 1.0 x MRPL, 1.5 x MRPL and 2.0 x MRPL on three different days. 303 
Intermediate precision as within-laboratory reproducibility was determined by analyzing two 304 
replicates of each matrix spiked at 1.0 x MRPL, 1.5 x MRPL and 2.0 x MRPL on three 305 
different days. Results from both the repeatability experiments and the intermediate precision 306 
experiments were combined to calculate the within-laboratory reproducibility. 307 
Measurement uncertainty (MU) was evaluated since this is an important requirement 308 
of ISO 17025 and accreditation. MU was calculated using the relative standard deviation 309 
(RSD) from the within-laboratory reproducibility using a coverage factor of two followed by 310 
adding five percent points due to the limited traceability of the trueness, using the formula  311 
𝑀𝑈 (%) = 2 𝑥 𝑅𝑆𝐷 (%) + 5 (%) 312 
 313 
and finally rounding up to the nearest 5%. 314 
Stability of the analytes in neat solutions and in matrix was determined by storing 10 315 
standards at -20 ºC in the dark, 10 standards at +4 ºC in the dark, 10 standards at room 316 
temperature in the dark and 10 standards at room temperature in daylight. In addition 5 blanks 317 
of each matrix was spiked at 5 ng and stored at -20 ºC in the dark. One standard and one 318 
spiked matrix blank from each storage condition was analyzed after one day, one week, two 319 
weeks etc. until the validation study was finished after eight weeks.  320 
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Ruggedness/robustness was evaluated using different batches of reagents, solutions 321 
and personnel during the eight weeks of the the validation study. Experience from later 322 
routine use of the method, and participation in proficiency tests, allows for a more long term 323 
evaluation of the robustness of the method. 324 
 325 
3. Results 326 
3.1 Selectivity/specificity 327 
Full chromatographic separation of the four analytes was achieved with equivalent peak 328 
shapes in sample and standards. A typical chromatogram of standard is shown in Figure 1. 329 
Isotope labelled internal standards were used in the determination to ensure robust 330 
determinations since they are known to equalize matrix effects and they make it possible to 331 
unambiguously identify an analyte’s retention time . Ion ratios were found to be quite similar 332 
from day to day and all the ratios were within the maximum permitted tolerances fulfilling the 333 
criteria for unequivocal identification of all the NF metabolites (Supplementary Table 1).  334 
During validation no interfering signals were detected in the blank samples. Later routine 335 
analysis revealed that e.g. scampi could contain possible false positive signals for NP-AHD 336 
with the same quantifier and qualifier ion within the expected ratio-interval as the analyte 337 
(Figure 2). However, the use of the mass labeled internal standard for AHD proved that the 338 
retention time for these false positive signals were not due to AHD. The signals could 339 
possibly be due to other compounds with similar structures. This demonstrates the importance 340 
of using isotope labeled internal standards since retention times may vary from injection to 341 
injection depending on the system stability and matrix load on the column. The use of isotope 342 
labelled internal standards is particularly important when determining illegal substances such 343 
as NF metabolites, or other compounds where false positives may lead to serious economic 344 
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damage for the producer. Preferably 13C or 15N labeled internal standards should be used since 345 
they have more similar retention time to the unlabeled analyte compared with 2H labeled 346 
internal standards (see e.g. the chromatogram of NP-AMOZ in Figure 1). It is well known that 347 
SEM can contain false positive signals due to the legitimate use of food packaging or food 348 
additives, but to our knowledge, this is the first time a false positive for AHD is reported. 349 
 350 
3.2 Calibration curves and working range 351 
Linear working ranges for the NF metabolites spanned from CCα to the highest level in the 352 
calibration curve (10 ng/g). Higher concentration levels were not anticipated to be necessary 353 
since samples with a concentration of any NF metabolite above CCα would be in violation of 354 
the legal limit. Calibration curves were calculated using linear regression analysis with 5-7 355 
concentration levels by forcing the curve through origo and weighting each observation with 356 
1/x. RSDs for the calibration curves were better than or equal to 12% for all analytes, and 357 
correlation coefficients were better than 0.99 on all days (Supplementary Table 2). 358 
 359 
3.3 Decision limit (CCα) 360 
Results for CCα determined using the three methods outlined in section 2.7; sample blank 361 
method, calibration curve method and ISO 11843 method are shown in Table 3. Using the 362 
sample blank method, the CCα was found to be between 0.1 ng/g wet weight (w.w.) and up to 363 
0.3 ng/g w.w. for AOZ in salmon. The calibration curve method gave CCα values in the range 364 
between 0.2 ng/g w.w. for AHD in shrimp up to 0.5 ng/g w.w. for SEM in both salmon and 365 
shrimp and AHD in salmon. The ISO 11843 method gave CCα values between 0.2 ng/g w.w. 366 
and up to 0.8 ng/g w.w. for AOZ in shrimp. CCα was always found to be under the MRPL (1 367 
ng/g w.w.) for all analyte-matrix combinations using all calculation methods. The three 368 
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methods used to determine CCα had small variations for most analyte-matrix combinations, 369 
but the difference was larger for e.g. AOZ in shrimp where the difference was 0.6 ng/g w.w. 370 
between the sample blank method (0.2 ng/g w.w.) and the ISO 11843 method (0.8 ng/g w.w.). 371 
CCαs found using the calibration curve approach and the ISO 11843 method were always 372 
higher than the CCαs found using the sample blank method. This could in part be due to the 373 
very low background noise in modern MS/MS-instruments, resulting in very low S/N in 374 
sample blanks. Since the instrument sensitivity will vary from day to day and from matrix to 375 
matrix, the determination of CCα in every instrument sequence has been suggested (E. 376 
Verdon, Hurtaud-Pessel, & Sanders, 2006). However, as our results show, CCα is also 377 
dependent on the method used to calculate it. Nevertheless, all results for CCα for this method 378 
will also fulfill the future criteria for reference points for action (RPA) proposed at 0.5 ng/g, 379 
except when using the ISO 11843 method to calculate the CCα for AOZ in shrimp (0.8 ng/g 380 
w.w.) (EC, 2019). 381 
 382 
3.4 Detection limit (CCβ) 383 
 CCβ was determined following the determination of CCα by spiking 24 matrix blanks 384 
of each matrix at CCα. Since the values of CCα was found to be both matrix, analyte and 385 
calculation dependent, samples were spiked at a selected level in the ranges of the found 386 
CCαs. CCβ results were then calculated for each matrix and analyte combination and the 387 
results are shown in Table 3. CCβ was found to be between 0.3 ng/g w.w. for AHD in shrimp 388 
and 0.9 ng/g w.w for AHD in cod. 389 
 390 
3.5 Recovery  391 
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Recovery was evaluated by spiking experiments. Samples of salmon, shrimp and cod were 392 
spiked at three levels and the results are shown in Supplementary Table 3. Recoveries for all 393 
analytes were found to be in the ranges 89-101% for salmon, 93-115% for shrimp and 84-394 
112% for cod. The results were within the criteria of 50-120% for concentrations at or below 395 
1 ng/g and mostly within 70-110% for concentrations above 1 ng/g and up to 10 ng/g. The 396 
exceptions were 2 ng/g of AHD in shrimp (115%) and 2 ng/g AHD in cod (112%). 397 
Nevertheless, such concentrations are well above the CCα and any detection at this 398 
concentration would therefore be illegal. 399 
 400 
3.6 Trueness 401 
To evaluate the trueness of the method a proficiency test of shrimp (SEM consensus value 402 
2.77 ng/g w.w.) was also analyzed during validation. We found 2.7 ng/g w.w. of SEM in this 403 
sample which gave a z-score of 0.0. The method has participated in many proficiency tests 404 
since it was first validated and the results have shown that other analyte-matrix combinations 405 
also result in z-scores less than |2| (Figure 3). In 2016 we had an exceptional high value  for 406 
tissue bound AOZ in shrimp with a z-score +3.3. When this result was reported we had used 407 
washing procedure 1 to report the amount of tissue bound NF metabolites. Due to our high z-408 
score in this proficiency test we decided to try to modify our washing procedure by adding a 409 
stone for better mixing during shaking. At the same time we also tested a different washing 410 
procedure 2 for comparison, published by the EURL for veterinary drugs (see 2.4 for details), 411 
and also modified this washing procedure by adding the stone for better mixing. Following 412 
the modification with the stone both washing procedures 1 and 2 produced satisfactory results 413 
with z-scores of -1.4 for washing procedure 1 and -1.7 for washing procedure 2. However, we 414 
noticed that our results were now on the lower side of the z-score scale, and we suspected this 415 
to be due to the increased loss of sample/analyte due to adsorption to the stone. We therefore 416 
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compared the old washing procedure 1 and the new washing procedure 2 without adding the 417 
stone (Supplementary Table 4 and 5). We found that the new washing procedure 2 was more 418 
efficient in removing particularly SEM and AOZ, which could explain why we got the high z-419 
score for AOZ when using the old washing method 1. We therefore changed to the new 420 
washing procedure 2 for future analyses when determining tissue bound NF metabolites. 421 
 422 
3.7 Precision as repeatability 423 
Repeatability (Supplementary Table 6) determined by analyzing salmon spiked at 1, 1.5 and 2 424 
ng/g w.w using six replicates on three different days gave RSDs between 0.7% for AMOZ at 425 
1 ng/g w.w. and 10% for AHD at 1 ng/g w.w.. Hence, repeatability of the method was within 426 
the 12% criteria for half the value predicted for reproducibility by the Horwitz equation, and 427 
well within the upper criteria of two thirds (15%) of the value predicted by the Horwitz 428 
equation. 429 
 430 
3.8 Intermediate precision/within-laboratory reproducibility 431 
Intermediate precision for salmon was determined by combining the results from 432 
repeatability testing (3.7) with two replicates on three different days, giving a larger dataset 433 
spanning six days in total (Supplementary Table 7). For shrimp and cod two replicates were 434 
analyzed on six different days. Intermediate precision RSDs ranged from 3.1% for 2 ng/g 435 
w.w. SEM in shrimp up to 17% for 1 ng/g w.w. of both AHD in cod and AOZ in shrimp. 436 
Hence, the within-laboratory reproducibility of the method was within the maximum 437 




3.9 Measurement uncertainty (MU) 440 
A “worst case” approach was chosen for the estimation of measurement uncertainty by 441 
selecting the highest within-laboratory reproducibility per matrix and using this RSD in the 442 
calculation of MU as specified in section 2.7. Calculated values for MU are shown in 443 
Supplementary Table 8. The within-laboratory reproducibility per matrix-analyte combination 444 
was found to vary from 7.2% for SEM in cod to 17% for AHD in cod and AOZ in shrimp. 445 
The associated calculated MU was estimated to vary between 20% for SEM in cod to 40% for 446 
AHD in cod and AOZ in shrimp. 447 
 448 
3.10 Stability 449 
Stability of the standards were investigated as described in section 2.7. One of the samples 450 
from each storage condition was worked up together with the other samples on every day of 451 
the validation. Linear regression analysis of the results was performed following complete 452 
validation after eight weeks and the results are shown in Supplementary Table 9. The analysis 453 
revealed no significant negative trend (p-values > 0.05) during the validation period for the 454 
analytes with the exception of AOZ stored in the dark at room temperature (p-value 0.05). 455 
However, this significant result could be due to chance, since AOZ stored at both -20 °C and 456 
+4 °C were not found to decrease significantly. The lack of significant trends should be 457 
interpreted with caution since all analytes, except AHD (+0.01 ng/day) stored in the dark and 458 
AMOZ in cod (0.00 ng/day), displayed negative correlation coefficients has high as -0.08 459 
ng/day. The regression coefficients for SEM (average -0,05 ng/day) were significantly (p < 460 
0.005) more negative than for the other NF metabolites (average -0.01 ng/day). This is 461 
consistent with previous investigations where stock solutions of NF metabolites were found to 462 
be stable for at least 10 months if stored at -4 °C, whereas more dilute solutions were found to 463 
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be stable for three months with the exception of SEM which was found to decompose at a rate 464 
of 5% during 3.9 months in dilute solutions (Cooper & Kennedy, 2007; Radovnikovic, 465 
Moloney, Byrne, & Danaher, 2011). Our decomposition rate for SEM was faster with an 466 
overall average of 1% per day. We also found that regression coefficients for SEM in matrix 467 
(average -0,08 ng/day) were significantly more negative (p< 0.0005) than regression 468 
coefficients in solution (average -0.04 ng/day), so care should be taken when storing samples 469 
with SEM. 470 
 471 
3.11 Ruggedness/robustness 472 
The method was found to be robust during the eight weeks of validation and has also proved 473 
to be robust during routine use performed by different personnel, using different batches of 474 
regents, solutions and standards over several years. The main factors, which may influence 475 
the robustness, was found to be the preparation and storage of standards and the pH 476 
adjustment. 477 
 478 
4. Conclusion 479 
The method was successfully validated and implemented for the determination of both tissue 480 
bound NF metabolites and total (free + tissue bound) NF metabolite residues and has been 481 
used in routine analysis for many years. Washing procedure 2 turned out to be the most 482 
efficient in removing free metabolites when determining tissue bound NF metabolites, 483 
particularly for SEM and AOZ. The two washing procedures we investigated differs to some 484 
extent in type and amount of solvent, but the main difference appears to be the more thorough 485 
homogenization, followed by centrifugation, for washing procedure 2 compared to the more 486 
gentle mixing and decanting of washing procedure 1. 487 
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A new false positive for AHD is reported for the first time and an isotope labeled internal 488 
standard is required for identifying this new false positive. This is because the false positive 489 
has identical response in the mass spectrometer compared to AHD, but the slight shift in 490 
retention time, compared to the isotope labeled internal standard, makes it possible to identify 491 
this false positive. 492 
The CCα of the method was satisfactory with respect to the MRPL using all the three methods 493 
for its calculation. Small differences in CCα were found when using the different calculation 494 
methods. Calculations using the sample blank method generally gave the lowest CCα of the 495 
investigated calculation methods. 496 
No statistically significant negative trends were seen from the stability investigations, 497 
although most NF metabolites had negative correlation coefficients. SEM had the highest 498 
negative correlation coefficient and decomposed at a rate of around 1% per day. 499 
The analytical method was found fit for purpose to determine both bound and total NF 500 
metabolites. The selection of validated matrixes, results from proficiency tests and routine use 501 
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